Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haydeh Payami

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2017
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiomeErin M Hill-Burns, Justine W Debelius, James T Morton, et al.
Genetic Testing|October 6, 2006
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's diseaseDenise M Kay, Tom D Bird, Cyrus P Zabetian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2007
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease riskKaren M Powers, Denise M Kay, Stewart A Factor, et al.
Neurogenetics|January 17, 2007
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor, Mary M Hulihan, Jennifer M Kachergus, et al.
Annals of Neurology|May 22, 2007
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseCyrus P Zabetian, Carolyn M Hutter, Stewart A Factor, et al.
European Journal of Neurology|December 21, 2007
Lack of evidence for an association between UCHL1 S18Y and Parkinson's diseaseCarolyn M Hutter, Ali Samii, Stewart A Factor, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 12, 2008
Genetic association between alpha-synuclein and idiopathic Parkinson's diseaseDenise M Kay, Stewart A Factor, Ali Samii, et al.
American Journal of Human Genetics|September 9, 2006
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia agoCyrus P Zabetian, Carolyn M Hutter, Dora Yearout, et al.
American Journal of Human Genetics|February 24, 2005
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus, Ignacio F Mata, Mary Hulihan, et al.
Human Molecular Genetics|July 13, 2016
Identification of genetic modifiers of age-at-onset for familial Parkinson's diseaseErin M Hill-Burns, Owen A Ross, William T Wissemann, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2017
Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiomeErin M Hill-Burns, Justine W Debelius, James T Morton, et al.
Genetic Testing|October 6, 2006
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's diseaseDenise M Kay, Tom D Bird, Cyrus P Zabetian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 8, 2007
Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease riskKaren M Powers, Denise M Kay, Stewart A Factor, et al.
Neurogenetics|January 17, 2007
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor, Mary M Hulihan, Jennifer M Kachergus, et al.
Annals of Neurology|May 22, 2007
Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's diseaseCyrus P Zabetian, Carolyn M Hutter, Stewart A Factor, et al.
European Journal of Neurology|December 21, 2007
Lack of evidence for an association between UCHL1 S18Y and Parkinson's diseaseCarolyn M Hutter, Ali Samii, Stewart A Factor, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 12, 2008
Genetic association between alpha-synuclein and idiopathic Parkinson's diseaseDenise M Kay, Stewart A Factor, Ali Samii, et al.
American Journal of Human Genetics|September 9, 2006
LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia agoCyrus P Zabetian, Carolyn M Hutter, Dora Yearout, et al.
American Journal of Human Genetics|February 24, 2005
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus, Ignacio F Mata, Mary Hulihan, et al.
Human Molecular Genetics|July 13, 2016
Identification of genetic modifiers of age-at-onset for familial Parkinson's diseaseErin M Hill-Burns, Owen A Ross, William T Wissemann, et al.
Pageof 7